The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
Open accessAbstract
Brain sigma-type receptors are thought to mediate hallucinogenic effects of certain benzomorphan opiates in humans. The biochemical characterization of sigma receptors has been difficult because of the lack of potent and selective ligands. We report here the synthesis and characterization of a tritiated, symmetrically substituted guanidine derivative, 1,3-di(2-[5-3H]tolyl)guanidine ([3H]Tol2Gdn), that binds with high affinity to a single population of binding sites in guinea pig brain membrane preparations. The [3H]Tol2Gdn binding site displays stereoselectivity for dextrorotatory optical isomers of benzomorphan opiates known to have sigma-type behavioral effects. Furthermore, the [3H]Tol2Gdn binding site has a high affinity for haloperidol and for phenothiazine antipsychotics, which have antihallucinatory properties in humans. The drug-selectivity profile of [3H]Tol2Gdn binding closely correlates with the drug-selectivity profile of tritiated (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine [+)-[3H]3-PPP) binding to guinea pig brain membrane receptors. (+)-[3H]3-PPP has been proposed to be a selective sigma-receptor ligand [Largent, B. L., Gundlach, A. L. & Snyder, S. H. (1984) Proc. Natl. Acad. Sci. USA 82, 4983-4987]. Receptor autoradiography using [3H]Tol2Gdn on slide-mounted rat and guinea pig brain sections reveals a heterogeneous distribution pattern of enriched binding in limbic and sensorimotor structures of the brain. These results indicate that [3H]Tol2Gdn is a selective ligand for the sigma-site. Availability of this sigma-receptor probe should greatly facilitate the physiological, biochemical, and pharmacological characterization of sigma receptors in brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,429
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Seeman, P. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06839-5 · Cited by 1,892
A practical computer-based approach to the analysis of radioligand binding experiments
McPherson, G. A. (1983) · Computer Programs in Biomedicine · doi:10.1016/0010-468x(83)90031-4 · Cited by 829
CLASSIFICATION OF OPIOID RECEPTORS
PATERSON, S. J., ROBSON, L. E., & KOSTERLITZ, H. W. (1983) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071787 · Cited by 790
Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography.
Goodman, R. R., Snyder, S. H., Kuhar, M. J., & Young, W. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.10.6239 · Cited by 466
Herkenham, M., & Pert, C. (1982) · The Journal of Neuroscience · doi:10.1523/jneurosci.02-08-01129.1982 · Cited by 465
Su, T. P. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33330-6 · Cited by 436
Tam, S. W., & Cook, L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5618 · Cited by 349
Largent, B. L., Gundlach, A. L., & Snyder, S. H. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24925-4 · Cited by 347
Cited by
Steroid Binding at σ Receptors Suggests a Link Between Endocrine, Nervous, and Immune Systems
Su, T.-P., London, E. D., & Jaffe, J. H. (1988) · Science · doi:10.1126/science.2832949 · Cited by 546
The sigma-1 receptor chaperone as an inter-organelle signaling modulator
Su, T.-P., Hayashi, T., Maurice, T., Buch, S., & Ruoho, A. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.007 · Cited by 466
[3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes
Wong, E. H. F., Knight, A. R., & Woodruff, G. N. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb13260.x · Cited by 454
Monnet, F. P., Mahé, V, Robel, P., & Baulieu, E. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3774 · Cited by 429
Hellewell, S. B., Bruce, A., Feinstein, G., Orringer, J., Williams, W., & Bowen, W. D. (1994) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(94)90115-5 · Cited by 390
D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons
Dragunow, M., Robertson, G. S., Faull, R. L. M., Robertson, H. A., & Jansen, K. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90399-o · Cited by 341
Matsumoto, R. R., Bowen, W. D., Tom, M. A., Vo, V. N., Truong, D. D., & De Costa, B. R. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00208-3 · Cited by 268
Sánchez, C., & Meier, E. (1997) · Psychopharmacology · doi:10.1007/s002130050181 · Cited by 255
Chu, U. B., Mavlyutov, T. A., Chu, M.-L., Yang, H., Schulman, A., Mesangeau, C., McCurdy, C. R., Guo, L.-W., & Ruoho, A. E. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.017 · Cited by 86
Persistent supersensitivity of σ receptors develops during repeated methamphetamine treatment
Ujike, H., Okumura, K., Zushi, Y., Akiyama, K., & Otsuki, S. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90388-k · Cited by 44
Metadata
- Authors
- Weber, E., Sonders, M., Quarum, M., McLean, S., Pou, S., & Keana, J. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-11
- Volume
- 83
- Issue
- 22
- Pages
- 8784-8788
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2061633232
- Cited by
- 376
- References
- 28
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.